An interventional study of Maternal Breast Milk Odor and Safe Swaddling in Prematurity, sponsored by KTO Karatay University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 34 Weeks to 36 Weeks. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by KTO Karatay University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 247 studies in Premature Birth with a site in Turkey — 44 open to participants now, 49 under way, none of them phase 3. Premature Birth · Turkey.
Among the 247 studies in Premature Birth with a site in Turkey, this one is the 77th largest by enrollment of the 197 interventional ones that give a count, is one of 34 that started in 2024, is one of 192 with no phase, and was the 205th registered.
2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.
Browse Premature Birth studies →44 of the 247 studies in Premature Birth with a site in Turkey are open now. Recruiting first, the newest first:
Mersin University · Sites in Turkey
Ages 32 wk–37 mo
Kubra Nur Kabakcı Sarıdağ · Sites in Turkey
Ages 32 wk–37 wk · Healthy volunteers
Gazi University · Sites in Turkey
Ages 3 mo–12 mo
Ataturk University · Sites in Turkey
Ages 28 wk–32 wk · Healthy volunteers
Uludag University · Sites in Turkey
Ages 0 hrs–6 hrs
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.
This study: 34 Weeks to 36 Weeks · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
247 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 34 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 72 is below the median of 84 across 1,670 interventional studies indexed under Premature Birth.
Median enrollment 64 across the 197 interventional studies, 90 across the 49 observational. Of the 169 that completed or were terminated, 1 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 247 has an industry lead sponsor. The 10 most frequent:
KTO Karatay University is the lead sponsor of 128 studies on the registry; 16 are open to participants now.
KTO Karatay University has 2 studies filed under Premature Birth — fewer than ten, so there is no comparison to draw.
9 of the studies in Premature Birth with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07864298Uskudar UniversityCohesive Bandage Fixation of Pulse Oximeter Probes and Skin Condition in Preterm Neonates | 2026-11 |
| NCT07525167Konya City HospitalEarly Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data | 2026-12-01 |
| NCT06823115Indiana UniversityAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | 2027-01 |
| NCT07917871Marmara UniversityEffects of Environmental Comfort and Oral Motor Stimulation on Comfort and Oral Feeding Readiness in Preterm Infants | 2027-01-01 |
| NCT07350018Uludag UniversityCalfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome | 2027-02-20 |
Add all 9 to your calendar (.ics) → With an account.
Among the 247 studies in Premature Birth with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study compared two approaches to reducing stress and improving comfort in babies born between 34 and 36 completed weeks of pregnancy who were receiving high-flow breathing support through small tubes in the nose.
Seventy-two babies were assigned by chance to one of three groups, with 24 babies in each group. One group was gently swaddled for 20 minutes. A second group was exposed for 20 minutes to the smell of freshly expressed milk from each baby's own mother. The third group received the neonatal intensive care unit's usual care and was observed for 20 minutes.
The study team assessed stress and comfort and recorded heart rate, breathing rate, blood oxygen level, and body temperature at the start of the observation period and again at 5 and 20 minutes. The purpose was to compare how these measures changed over time across the three groups.
The criteria were revised on the registry on Nov 13, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Infants were exposed for 20 minutes to the odor of freshly expressed breast milk from their own mothers. Ten drops of milk were applied to sterile gauze placed in a sterile container. The container was positioned inside the incubator approximately 1-2 cm from the infant's nose and remained in place throughout the exposure period.
Other: Maternal Breast Milk Odor
Infants were positioned supine and swaddled for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The upper limbs were held alongside the trunk in slight flexion. The lower limbs were left free to allow hip flexion and abduction. The cloth was secured loosely enough to permit chest expansion and spontaneous movement.
Other: Safe Swaddling
Infants received the neonatal intensive care unit's standard care during a 20-minute observation period. No additional study intervention was administered.
Ten drops of freshly expressed breast milk from each infant's own mother were applied to sterile gauze in a sterile container. The container was placed inside the incubator near the infant's nose for 20 minutes.
Infants were swaddled in the supine position for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The cloth was secured loosely to allow chest expansion and spontaneous movement, and the lower limbs were left free to permit hip flexion and abduction.
Change in Newborn Stress Scale Total Score Over Time
Stress was assessed using the Newborn Stress Scale. The scale comprises eight observational domains, each scored from 0 to 2. Total scores range from 0 to 16, with higher scores indicating greater stress. Changes in total scores across the three assessment time points were compared among the study groups.
Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Premature Infant Comfort Scale Total Score
Comfort was assessed using the Turkish version of the Premature Infant Comfort Scale. Seven indicators are each scored from 1 to 5. Total scores range from 7 to 35, with lower scores indicating greater comfort.
Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Heart Rate
Heart rate was read directly from the bedside monitor and recorded in beats per minute.
Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Respiratory Rate
Respiratory rate was read directly from the bedside monitor and recorded in breaths per minute.
Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Peripheral Oxygen Saturation (SpO₂)
Peripheral oxygen saturation was read directly from the bedside monitor and recorded as a percentage.
Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Body Temperature
Body temperature was read directly from the bedside monitor and recorded in degrees Celsius (°C).
Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Plan to share: No — Security
No publications or documents are linked to this record.
Ran from Jun 2024 to primary completion in Apr 2026, 22 months.
Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's 22 months is close to that.
Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.
Primary completion moved once since we started tracking on Sep 25, 2026: Aug 2025 → Apr 2026, on Nov 13, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.